Navigation Links
Tumor wizardry wards off attacks from the immune system

Like the fictional wizard Harry Potter, some cancerous tumors seem capable of wrapping themselves in an invisibility cloak. Researchers at Washington University School of Medicine in St. Louis have found that pancreatic tumors hide from the body's immune surveillance by surrounding themselves with cells that make it hard for the immune system to detect them.

The tumor-protecting cells are white blood cells called regulatory T cells, or T-reg for short. Under ordinary circumstances, T-reg cells inhibit immune components responsible for killing unwanted cells -- this allows T-reg cells to help prevent autoimmune reactions.

The scientists discovered that cancerous cells take advantage of T-reg cells' suppressor ability, enlisting them to keep the immune system at bay. Their report appears in the July/August issue of the Journal of Immunotherapy.

"Earlier, we found that T-reg cells are much more prevalent in patients with breast cancer and pancreatic cancer than in healthy patients," says David C. Linehan, M.D., associate professor of surgery and a researcher with the Siteman Cancer Center. "The new findings show that tumors are directly responsible for the increase of T-reg cells and can attract T-reg cells to their vicinity. This could be one way for tumors to evade immune surveillance."

Linehan believes this could explain the failure of many experimental anti-cancer vaccines. Such vaccines are designed to rev up the immune response to cancer cells so that the immune system can attack tumors. But a tumor shielded with T-reg cells could potentially circumvent the immune system's attack and remain safe.

In mice implanted with pancreatic cancer, the researchers demonstrated that tumor growth caused an increase in T-reg cells in both the blood stream and in lymph nodes leading from the tumors.

When the research team blocked a signaling molecule that pancreatic tumors secrete in abundance, T-reg cells were no longer present in the tumor-draining lymph nodes, suggesting that this signaling molecule, referred to as TGF-beta, has an important role in weaving a tumor's cloak of invisibility. Such information could lead to a method for blocking tumors from using T-reg cells for protection. Other research by Linehan and colleagues showed that in mice with pancreatic cancer, simply depleting T-reg cells slowed tumor growth and increased survival time.

"We're looking at several potential ways to interfere with tumor recruitment of T-reg cells," Linehan says. "We'd like to see these findings advance cancer immunotherapy. We want to find a way to actively suppress T-reg cells and at the same time actively evoke an immune response to tumor-specific antigens."

In collaboration with other researchers at the School of Medicine, Linehan is planning to set up a clinical trial that pairs T-reg depletion with anti-cancer vaccine as a therapy for pancreatic cancer patients.

"We're attacking the problem from different angles hoping to translate these findings to our patients," Linehan says. "Right now, no effective treatment exists for pancreatic cancer."


Source:Washington University School of Medicine

Related biology news :

1. Missing Receptor Molecule Causes Tumor Growth
2. Stem Cells Found In Cerebellum; Possible Cell of Origin for Childhood Brain Tumors
3. New Therapeutic Target Identified In Inherited Brain Tumor Disorder
4. Tumor cells that border normal tissue are told to leave
5. Tumor cells evade death through autophagy
6. Tumor-suppressor gene is critical for placenta development
7. Towards precise classification of cancers based on robust gene functional expression profiles
8. Virologists make major step towards understanding the process of HIV infection
9. Cats indifference towards sugar explained
10. Survey Uncovers Surprising Attitudes Towards HIV Vaccine Research
11. A new step towards an AIDS vaccine
Post Your Comments:

(Date:11/17/2015)... Nov. 17, 2015 Pressure BioSciences, Inc. (OTCQB: ... development and sale of broadly enabling, pressure cycling technology ... industry, today announced it has received gross proceeds of ... Private Placement (the "Offering"), increasing the total amount raised ... more additional closings are expected in the near future. ...
(Date:11/11/2015)... , Nov. 11, 2015   MedNet Solutions , an ... of clinical research, is pleased to announce that it will ... Trials (PCT) event, to be held November 17-19 in ... to view live demonstrations of iMedNet , ... how iMedNet has been able to deliver time ...
(Date:11/4/2015)... November 4, 2015 --> ... report published by Transparency Market Research "Home Security Solutions Market ... Forecast 2015 - 2022", the global home security solutions market is ... by 2022. The market is estimated to expand at ... 2015 to 2022. Rising security needs among customers at ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... 2015 The Global Genomics ... professional and in-depth study on the current state ... ) , The report ... definitions, classifications, applications and industry chain structure. The ... markets including development trends, competitive landscape analysis, and ...
(Date:11/24/2015)... Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will be ... York on Wednesday, December 2 at 9:30 a.m. ET/6:30 ... CEO, will provide a corporate overview. th Annual ... 1:00 p.m. ET/10:00 a.m. PT . Jim Mazzola , ... corporate overview. --> th Annual Oppenheimer Healthcare Conference ...
(Date:11/24/2015)... Inc., a worldwide provider of clinical research services headquartered in ... has set a new quarterly earnings record in Q3 of 2015.  ... Q3 of 2014 to Q3 of 2015.   ... the establishment of an Asia-Pacific office to ... and Mexico , with the establishment ...
(Date:11/24/2015)... York , November 24, 2015 ... a recent market research report released by Transparency Market ... to expand at a CAGR of 17.5% during the ... Prenatal Testing Market - Global Industry Analysis, Size, Volume, ... the global non-invasive prenatal testing market to reach a ...
Breaking Biology Technology: